Kazden Ingram

Title: Kazden Ingram: Innovator in Pharmaceutical Formulations

Introduction

Kazden Ingram is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms for medications. With a total of 3 patents to his name, Ingram's work focuses on improving drug delivery systems.

Latest Patents

Ingram's latest patents revolve around formulations of apremilast. These patents describe oral dosage forms that include a core tablet with a drug layer comprising apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion. The core tablet also features a swellable layer made of one or more swellable polymers, along with a coating layer that has at least one drug release orifice. These innovative oral dosage forms are designed for once-a-day dosing of apremilast and are suitable for treating diseases or disorders that can be improved by inhibiting phosphodiesterase subtype IV (PDE4).

Career Highlights

Kazden Ingram is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on developing advanced pharmaceutical formulations that enhance patient care and treatment outcomes.

Collaborations

Ingram has collaborated with notable colleagues such as Nathan Bennette and William Brett Caldwell. These partnerships have contributed to the successful development of his innovative formulations.

Conclusion

Kazden Ingram's contributions to pharmaceutical innovations, particularly in the area of apremilast formulations, highlight his role as a key inventor in the industry. His work continues to impact the field of drug delivery and patient treatment.